New for 2022: Food and Drug Administration Approvals of Pediatric Respiratory Medications.

Bickel, Scott; Eid, Nemr; Delaney, Matthew; Morton, Ronald

Bickel, Scott; Eid, Nemr; Delaney, Matthew; Morton, Ronald.

Afiliação

Bickel S; Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, University of Louisville, Norton Children's and University of Louisville School of Medicine, Louisville, Kentucky, USA.
Eid N; Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, University of Louisville, Norton Children's and University of Louisville School of Medicine, Louisville, Kentucky, USA.
Delaney M; Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, University of Louisville, Norton Children's and University of Louisville School of Medicine, Louisville, Kentucky, USA.
Morton R; Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, University of Louisville, Norton Children's and University of Louisville School of Medicine, Louisville, Kentucky, USA.

Pediatr Allergy Immunol Pulmonol ; 36(2): 37-40, 2023 06.

Article em En | MEDLINE | ID: mdl-37159398

Assuntos

Aprovação de Drogas; Estados Unidos; Humanos; Criança; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aprovação de Drogas Limite: Child / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google